Departed
Paul S. Beeber
Director
NSSC ·
NAPCO SECURITY TECHNOLOGIES, INC
On September 17, 2024, Paul S. Beeber resigned as a director of the Company effective as of that date.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7201–7250 of 33502
Departed
Richard H. Deily
Chief Financial Officer
AGX ·
ARGAN INC
Richard H. Deily who retired as Chief Financial Officer on September 15, 2024
Departed
David Helmreich
Chief Commercial Officer
Innovid Corp.
Innovid Corp. (the “Company”) announces that it has agreed to the terms of a mutual separation agreement dated September 15, 2024 (the “Mutual Separation Agreement”), which is expected to become effective as of September 21, 2024, by and between the Company and its former Chief Commercial Officer, David Helmreich, who left the Company by mutual consent effective as of the close of business on August 30, 2024 (the “Separation Date”).
Departed
Tracy Layney
Executive Vice President and Chief Human Resources Officer
LEVI ·
LEVI STRAUSS & CO
Tracy Layney, will cease serving as Executive Vice President and Chief Human Resources Officer on or about October 11, 2024.
Departed
James Hassard
Chief Commercial Officer
CRNX ·
Crinetics Pharmaceuticals, Inc.
On September 13, 2024, Crinetics Pharmaceuticals, Inc. (the “Company”) determined that James Hassard will separate from the Company and will cease serving as the Chief Commercial Officer, effective October 14, 2024.
Departed
Vittal Vasista
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
RGNX ·
REGENXBIO Inc.
the Board accepted the resignation of Vittal Vasista from his position as Executive Vice President, Chief Financial Officer and Principal Accounting Officer, effective as of September 16, 2024
Departed
Mark Bach
Chief Medical Officer
GPCR ·
Structure Therapeutics Inc.
On September 12, 2024, Mark Bach, M.D., Ph.D. entered into a separation and consulting agreement (the “Bach Separation and Consulting Agreement”) with Structure Therapeutics Inc. (the “Company”) in connection with his departure as Chief Medical Officer (“CMO”) as part of a planned succession, effective as of September 18, 2024 (the “Effective Date”).
Departed
Steve Merkt
President, Transportation Solutions
TEL ·
TE Connectivity plc
on September 11, 2024 the Company notified Steve Merkt of the termination of his employment.
Departed
Linda Jojo
Executive Vice President and Chief Customer Officer
UAL ·
United Airlines Holdings, Inc.
On September 16, 2024, Linda Jojo, Executive Vice President and Chief Customer Officer of United Airlines Holdings, Inc. (the “Company”), the parent company of United Airlines, Inc., informed the Company of her intention to retire from the Company, effective January 2, 2025.
Departed
James J. Marino
Director
TRAW ·
Traws Pharma, Inc.
On September 16, 2024, James J. Marino, a member of the Board of Directors (the “Board”) of Traws Pharma, Inc. (the “Company”), resigned as a director.
Departed
Jane E. DeFlorio
Director
SITC ·
SITE Centers Corp.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
Departed
Terrance R. Ahern
Director
SITC ·
SITE Centers Corp.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
Departed
Barry A. Sholem
Director
SITC ·
SITE Centers Corp.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
Departed
Alexander Otto
Director
SITC ·
SITE Centers Corp.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
Departed
Linda B. Abraham
Director
SITC ·
SITE Centers Corp.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
Departed
Victor B. MacFarlane
Director
SITC ·
SITE Centers Corp.
On September 11, 2024, Linda B. Abraham, Terrance R. Ahern, Jane E. DeFlorio, Victor B. MacFarlane, Alexander Otto and Barry A. Sholem (collectively, the “ Resigning Directors ”) informed the Company of their intentions to resign from the Board, effective on the Antecedent Date.
Departed
Tamara Linde
Executive Vice President and General Counsel
PEG ·
PUBLIC SERVICE ENTERPRISE GROUP INC
On September 11, 2024, Tamara Linde notified Public Service Enterprise Group Incorporated (the Company) of her decision to retire as Executive Vice President and General Counsel of the Company.
Departed
John Seery
Director
ZNOG ·
ZION OIL & GAS INC
On July 8, 2024, Mr. John Seery retired from the Board of Directors
Departed
Ryan J. Faulkingham
regular trustee of the Trust
Compass Group Diversified Holdings LLC
Mr. Faulkingham resigned from all officer and director positions he held with the Manager, the Company and the Trust and their respective affiliates (including any committee thereof).
Departed
Ryan J. Faulkingham
Chief Financial Officer
Compass Group Diversified Holdings LLC
announced the departure of Ryan J. Faulkingham as the Chief Financial Officer of the Company and as a regular trustee of the Trust, each effective as of August 30, 2024.
Departed
Aneek S. Mamik
Director
OMF ·
OneMain Holdings, Inc.
On September 17, 2024, Aneek S. Mamik resigned from the Board of Directors (the “Board”) of OneMain Holdings, Inc. (the “Company”), effective immediately.
Departed
Dean Medwid
Chief Executive Officer
CPMD ·
CANNAPHARMARX, INC.
Dean Medwid stepped down as the Chief Executive Officer (“CEO”) of CannaPharmaRX, Inc. (the “Company”) for personal reasons.
Departed
David Heidecorn
director
BurgerFi International, Inc.
On September 16, 2024, David Heidecorn resigned from the board of directors of the Company, effective immediately.
Departed
Vanila M. Singh
member of the Board of Directors
Virpax Pharmaceuticals, Inc.
On September 16, 2024, Vanila M. Singh, MD, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Company of her intention to resign from the Board, effective immediately.
Departed
Kush Parmar
Member of the Board and Chair of the Nominating and Corporate Governance Committee
RLYB ·
Rallybio Corp
On September 16, 2024, Dr. Kush Parmar informed the Board of Directors (the Board) of Rallybio Corporation (Rallybio) that he intends to resign as a member of the Board and as Chair of the Nominating and Corporate Governance Committee of the Board effective October 31, 2024.
Departed
Anila Lingamneni
Executive Vice President, Chief Technology Officer
HAE ·
HAEMONETICS CORP
Anila Lingamneni, Executive Vice President, Chief Technology Officer, will leave Haemonetics Corporation (the “Company”) on November 1, 2024.
Departed
Michael Conway
chief executive officer, North America
SBUX ·
STARBUCKS CORP
On September 12, 2024, Michael Conway, chief executive officer, North America of Starbucks Corporation (the "Company") informed the Company of his intention to retire effective November 30, 2024.
Departed
Lisa Curtis
Executive Vice President, Chief Financial Officer
GVA ·
GRANITE CONSTRUCTION INC
On September 16, 2024, Lisa Curtis and the Company entered into a Separation and Transition Agreement (the “Agreement”).
Departed
(interim)
Craig C. MacKay
Interim President and Chief Executive Officer
CARV ·
CARVER BANCORP INC
Craig C. MacKay, who serves as Interim President and Chief Executive Officer of the Company and Bank, will resign as Interim President and Chief Executive Officer effective October 31, 2024, and Mr. MacKay will continue to serve as a member of the Board.
Departed
Michael Griffin
Director
RKLB ·
Rocket Lab Corp
On September 12, 2024, Michael Griffin notified Rocket Lab USA, Inc. (the “Company”) of his retirement and resignation as a member of the Company’s Board of Directors and the Board Committees on which he serves effective immediately.
Departed
Jeffrey L. Wade
President and Chief Operating Officer
LXRX ·
LEXICON PHARMACEUTICALS, INC.
On September 13, 2024, we and Jeffrey L. Wade determined that his employment as our president and chief operating officer (in which capacity, Mr. Wade has functioned as our principal financial officer) would terminate as of September 30, 2024.
Departed
Mario Vázquez
Director
MELI ·
MERCADOLIBRE INC
Mr. Mario Vázquez, one of the directors of the Company, died on August 3, 2024.
Departed
John Snisarenko
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Peter J. Pizzo, III
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Adam Morgan
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Michael Kaseta
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Maggie Pax
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Richard S. Eiswirth, Jr.
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Ross Demont
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Erin Parsons
Director
ALIMERA SCIENCES INC
each of Adam Morgan, Richard S. Eiswirth, Jr., Ross Demont, Michael Kaseta, Erin Parsons, Maggie Pax, Peter J. Pizzo, III and John Snisarenko ceased to be members of the Board of Directors of the Company (the “ Company Board ”) and ceased to be members of any committees of the Company Board on which such directors served, effective as of the Effective Time.
Departed
Ariel Hazzard
Chief Compliance Officer
BlackRock Private Credit Fund
On September 10, 2024, Ariel Hazzard, the Chief Compliance Officer (“CCO”) of BlackRock Private Credit Fund (the “Company”) began parental leave and Charles Park became Interim CCO.
Departed
Philip Tseng
President
TCPC ·
BlackRock TCP Capital Corp.
Mr. Tseng will continue to serve as President of the Company, BDLC and BlackRock Private Credit Fund (“BDEBT”) until the close of business on November 6, 2024.
Departed
Rajneesh Vig
Chair of the Board and Chief Executive Officer
TCPC ·
BlackRock TCP Capital Corp.
On September 16, 2024, Rajneesh Vig informed BlackRock TCP Capital Corp. (the “Company”) of his resignation from his positions as Chair of the Board of Directors of the Company and as Chief Executive Officer (“CEO”) of the Company, effective as of the close of business on November 6, 2024, to pursue other business opportunities outside of BlackRock, Inc.
Departed
Rajneesh Vig
Chair and Chief Executive Officer
BlackRock Direct Lending Corp.
On September 16, 2024, Rajneesh Vig informed BlackRock Direct Lending Corp. (the “Company”) of his resignation from his positions as Chair of the Board of Directors of the Company and as Chief Executive Officer (“CEO”) of the Company, effective as of the close of business on November 6, 2024, to pursue other business opportunities outside of BlackRock, Inc.
Departed
Thomas E. Davin
Director
BRCC ·
BRC Inc.
On September 13, 2024, Thomas E. Davin informed BRC Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective September 13, 2024, in order to devote time to personal endeavors.
Departed
B. Ben Baldanza
Director
JBLU ·
JETBLUE AIRWAYS CORP
On September 10, 2024, B. Ben Baldanza, a member of the Board of Directors (the “Board”) of JetBlue Airways Corporation (the “Company”) notified the Company that he decided to resign from the Board and, therefore, would not seek re-election to the Board at the Company’s 2025 Annual Meeting of Stockholders scheduled for May 2025.
Departed
J. Christopher Douglas
Executive Vice President and Chief Financial Officer
HR ·
Healthcare Realty Trust Inc
On September 10, 2024, Healthcare Realty Trust Incorporated (the “Company”) and J. Christopher Douglas determined that Mr. Douglas would depart from his position as Executive Vice President and Chief Financial Officer of the Company, effective October 1, 2024.
Departed
Elizabeth Gitajn
Senior Vice President, Finance & Controller and principal accounting officer
IMAX ·
IMAX CORP
On September 11, 2024, Elizabeth Gitajn, Senior Vice President, Finance & Controller and principal accounting officer of IMAX Corporation (the “Company”), notified the Company of her intent to resign from her position effective October 31, 2024 to accept another professional opportunity.
Departed
Matthew T. Farrell
President and Chief Executive Officer
CHD ·
CHURCH & DWIGHT CO INC /DE/
Matthew T. Farrell, Chairman and Chief Executive Officer of Church & Dwight Co., Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) that he will retire as President and Chief Executive Officer, effective as of March 31, 2025.
Departed
Fabrizio Bocciardi
trustee
MidCap Apollo Institutional Private Lending
On September 16, 2024, Fabrizio Bocciardi, a trustee on the Board of Trustees (the “ Board ”) of Middle Market Apollo Institutional Private Lending (the “ Company ”), informed the Company of his decision to resign as a member of the Board, effective September 16, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.